Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

Clinical trial NCT01053936 · COMPLETED

Trial details

NCT number: NCT01053936
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Insufficiency, Chronic Diabetes Mellitus, Type 2

Start date: 2010-01-31
Primary completion: 2010-12-31
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.